Povidone iodine mouthwash, gargle, nasal spray to reduce nasopharyngeal viral load in patients with COVID-19

What The Study Did:

Researchers in this randomized clinical trial investigated whether nasopharyngeal application of povidone iodine could reduce the viral load of patients with nonsevere COVID-19 symptoms.

Authors:

Olivier Mimoz, M.D., Ph.D., University Hospital of Poitiers in Poitiers, France, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamaoto.2020.5490)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamaotolaryngology/

fullarticle/

10.

1001/

jamaoto.

2020.

5490?guestAccessKey=

c60aee4d-d4da-4df2-ad4e-9482ac6400c5&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

020421